Novartis AG (NVS) Scrambles to Woo Vets Angry Over Production Problems
5/14/2013 7:41:17 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Now that Novartis has shrunk operations at its troubled Lincoln, Nebraska, plant, the drugmaker is scrambling to win back a key set of customers – veterinarians. And to do so, Novartis is cutting the price of its Sentinel tablets for flea and heartworm prevention for dogs – one of just three products that are now being made at the facility – nearly in half from 2011 levels. The idea, of course, is to convince vets to restock its medicine after a 16-month hiatus. Production, you recall, was halted early last year after the FDA found numerous serious and embarrassing manufacturing gaffes at the plant, including repeated failures to investigate customer complaints of foreign tablets found in packaged medicines and filing required field reports with the agency.
Help employers find you! Check out all the jobs and post your resume.
comments powered by